Skip to main content
David Lanfear, MD, Cardiology, Detroit, MI

DavidE.LanfearMDMS

Cardiology • Detroit, MI

Heart Failure & Transplantation

Section Head, Advanced Heart Failure and Transplantation, Henry Ford Hospital Associate Professor, Internal Medicine, Wayne State University School of Medicine

Join to view full profile

Dr. Lanfear is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lanfear's full profile

Already have an account?

  • Office

    Henry Ford Health System
    2799 West Grand Boulevard
    Detroit, MI 48202
    Phone+1 313-916-9106
    Fax+1 313-916-1249

Summary

  • Dr. David Lanfear is a cardiologist in Detroit, MI and is affiliated with Henry Ford Hospital. He received his medical degree from University of Michigan Medical School and has been in practice 19 years. He specializes in heart failure & transplantation and is experienced in echocardiography, cardiac critical care, heart failure and transplantation, vad management, and pharmacogenetics.

Education & Training

  • University of Michigan School of Public Health
    University of Michigan School of Public HealthMS, Biostatistics and Research Design, 2005 - 2007
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2001 - 2005
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2001
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1998

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2005 - 2027
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FAHA) American Heart Association, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure  
    John R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
  • Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome  
    David E Lanfear 1, Philip G Jones, Sharon Marsh, Sharon Cresci, Howard L McLeod, John A Spertus, JAMA, 9/28/2005

Lectures

  • Non-Invasive Markers for Precision Medicine in Transplant Emerging Science Coming to the Clinic 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Best Practices in Hear Failure: 'How to' With the Experts 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018
  • Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018

Press Mentions

  • Put It on the Board
    Put It on the BoardMay 18th, 2023
  • Illumina Taps Henry Ford Health System to Explore Whole-Genome Testing for Heart Disease
    Illumina Taps Henry Ford Health System to Explore Whole-Genome Testing for Heart DiseaseApril 17th, 2023
  • Illumina, Henry Ford Health Partner to Study Impact of CGP on Cardiovascular Disease
    Illumina, Henry Ford Health Partner to Study Impact of CGP on Cardiovascular DiseaseApril 11th, 2023
  • Join now to see all

Grant Support

  • Impact Of RACE And Genetic Factors On Beta-Blocker Effectiveness In Heart FailureNational Heart, Lung, And Blood Institute2011–2012
  • Pharmacogenetics Of The B-Type Natriuretic Peptide PathwayNational Heart, Lung, And Blood Institute2008–2011

Professional Memberships

Dr. David Lanfear, Dr. David Lanfear, MD, Dr. D Lanfear, Dr. David E. Lanfear